Product Information
TOLTERODINE TARTRATE 2 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2639 per EA under NDC 00093001806. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Feb 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093001806
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOLTERODINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077006FDA Approved
2/23/2015
TE Code
AB
On Market Since
11/1/2015
Pharmacological Classes
Price Statistics
The NADAC for TOLTERODINE TARTRATE 2 MG TAB has been published 542 times since May 18, 2016, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2639 per EA |
|---|---|
| All-time high | $1.5598 (Nov 16, 2016) |
| All-time low | $0.1912 (May 22, 2024) |
| 52-week high | $0.2639 |
| 52-week low | $0.2057 |
| Median price | $0.5359 |
| Average price | $0.5854 |
| Largest weekly change | +35.6% (Jun 19, 2024) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tolterodine Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOLTERODINE TARTRATE 2 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TOLTERODINE TARTRATE 2 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.2639 per EA (NDC 00093001806), effective Sep 30, 2026.
How has the price of TOLTERODINE TARTRATE 2 MG TAB changed over time?
Over the history we have for it, the NADAC for TOLTERODINE TARTRATE 2 MG TAB has declined 82.5%. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for TOLTERODINE TARTRATE 2 MG TAB?
Since May 18, 2016, the NADAC for TOLTERODINE TARTRATE 2 MG TAB has ranged from a low of $0.1912 (May 22, 2024) to a high of $1.5598 (Nov 16, 2016), with a median of $0.5359 per EA.
Are there cheaper alternatives to TOLTERODINE TARTRATE 2 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOLTERODINE TARTRATE 2 MG TAB, is $0.2483 per EA — about 6% below TOLTERODINE TARTRATE 2 MG TAB.
Who manufactures TOLTERODINE TARTRATE 2 MG TAB?
TOLTERODINE TARTRATE 2 MG TAB (NDC 00093001806) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.